Risk of drug-induced cardiac arrhythmia during COVID-19 therapeutic treatment
Abstract Therapeutic treatment of severe COVID-19 infection involves the administration of multiple pharmacologic agents to reduce the risk of serious complications; this may result in drug interactions and possible adverse reactions and induced cardiotoxicity. The risk–benefit ratio associated with...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | article |
| Language: | EN |
| Published: |
SpringerOpen
2021
|
| Subjects: | |
| Online Access: | https://doaj.org/article/40a3ae9a21a0429ea800947f1e0a5a57 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|